Seeking Solutions for Diabetes and Obesity
At AMR Clinical, we provided trusted clinical research site services for endocrinology/metabolic trials to improve outcomes and quality of life by developing innovative treatments and therapies for hormonal imbalances and metabolic disorders:
- 575+ endocrinology studies
- 100+ obesity/weight loss studies
- 23,500+ endocrinology participants enrolled
- 7,500+ obesity participants enrolled
- 122% average obesity clinical trial enrollment goals achieved
Experienced Support Staff
- Access to endocrinology, family medicine, and internal medicine practices
- Actigraphy experience
- Adult and adolescent obesity experience
- AMRA, PDFF, 1.5T and 3.0T MRI capabilities
- Clinical research support services for Phase I, II, III, and IV obesity protocols
- Device and diagnostic study experience in diabetic populations
- Dexa on-site or within 10 miles of clinic research sites with flexible scheduling to accommodate protocol requirements
- Experience with long-term outcome studies with 5-year patient retention in clinical trials
- Experience with flash glucose monitoring, continuous glucose monitoring
- Inpatient and/or hospital capabilities at multiple locations
- IV infusion experienced, licensed staff, infusion pumps, and appropriate seating to accommodate infusion procedures
- Phase I trial experience in diabetic populations
- Multiple routes of drug administration including oral, inhaled/intra-nasal, topical, injectable, and patch
- Staff thoroughly trained in diabetes and lifestyle modification counseling, EMGs, and nerve stimulation tests for DPN
- Specialized staff including endocrinologist and obesity medicine specialist investigators, licensed dieticians, and weight loss counselors
- Subject training, monitoring, and re-training as needed (eDiary, self-administration of IP, blood glucose measurement, etc.)
- Obesity experience with comorbid conditions (i.e., hypertension, diabetes, CV risk)
Research Done Right — Endocrinology/Metabolic Indications
- Atopic dermatitis
- CV co-morbidities
- Diabetes with kidney disease/hemodialysis
- Diabetic foot ulcers
- Diabetic peripheral neuropathy
- Metabolic syndrome
- MAFLD/NAFLD
- MASH/NASH
- Nutrition trials including infant formula
- Obesity/weight loss
- Obesity with osteoarthritis
- Pre-diabetes
- Psoriasis
- Stress urinary incontinence
- Type 1 diabetes
- Type 2 diabetes
Recent Endocrinology/Metabolic Approvals
| Sponsor | Asset | Indication | Population |
|---|---|---|---|
| Eli Lilly | Zepbound | Obesity | Adults |
| Eli Lilly | Mounjaro | Type 2 diabetes | Adults |
| Novo Nordisk | Wegovy | Type 2 diabetes/obesity | Adult/Adolescent |
| Novo Nordisk | Ozempic | Type 2 diabetes | Adults |
